跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31,454 条关于
“acute porphyria”
全部
31,454
临床试验
28,013
药物
277
机构
24
资讯
3,140
去年
Givlaari Approved in Switzerland for Acute Hepatic Porphyria Treatment
去年
Givlaari Demonstrates Effectiveness in AIP Patients Often Excluded from Clinical Trials
去年
FDA Approves Alnylam's Oxlumo as First Treatment for Ultra-Rare Kidney Disease PH1
2个月前
SCENESSE® (Afamelanotide) Approved by Health Canada for Erythropoietic Protoporphyria
去年
Alembic Pharmaceuticals Acquires UTILITY Therapeutics to Commercialize First New UTI Antibiotic in 20 Years
去年
Aera Therapeutics Names Bill Querbes as Chief Scientific Officer to Advance Genetic Medicine Pipeline
去年
CRISPR Therapeutics Reports Breakthrough Results from In Vivo Gene Therapy CTX310 for Heart Disease
去年
FDA Aligns with Gemini Therapeutics on APOLLO Trial Design for Bitopertin in Rare Porphyria Disorders
去年
Phase I/II Trial of Lu177-PentixaTher Initiated for Relapsed/Refractory AML and ALL
去年
Phase I/II Trial of Lu177-PentixaTher Initiated for Relapsed/Refractory AML and ALL
第 1 页,共 314 页
上一页
下一页